Research / CBT / Fundamental state Inspectable configuration
State dimensions Filing 0000950170-25-015513 General Corporate
Debt relative to revenue 45th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
125.44% · OPTIONAL · VALID
Capex intensity 85th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
8.06% · OPTIONAL · VALID
Operating cash generation 55th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
12.98% · OPTIONAL · VALID
Revenue growth 45th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
-0.31% · CORE · VALID
Inventory pressure 50th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
56.13% · OPTIONAL · VALID
Gross margin 85th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
24.61% · CORE · VALID
Operating margin 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
16.23% · CORE · VALID
R&D intensity 40th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.47% · OPTIONAL · VALID
SBC intensity 100th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.84% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 36 states Self-history eligible
Sep 30, 2021 9/9 normalized Level 3 Dec 31, 2021 9/9 normalized Level 3 Mar 31, 2022 9/9 normalized Level 3 Jun 30, 2022 9/9 normalized Level 3 Sep 30, 2022 9/9 normalized Level 3 Dec 31, 2022 9/9 normalized Level 3 Mar 31, 2023 9/9 normalized Level 3 Jun 30, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Dec 31, 2023 9/9 normalized Level 3 Mar 31, 2024 9/9 normalized Level 3 Jun 30, 2024 9/9 normalized Level 3 Sep 30, 2024 9/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 26.92%
Current 125.44%
Delta 98.53% Capex Intensity Increased
Previous 6.03%
Current 8.06%
Delta 2.03% Cash Generation Decreased
Previous 17.33%
Current 12.98%
Delta -4.34% Growth Decreased
Previous 1.60%
Current -0.31%
Delta -1.92% Inventory Pressure Increased
Previous 13.82%
Current 56.13%
Delta 42.30% Margin Increased
Previous 24.04%
Current 24.61%
Delta 0.57% Profitability Increased
Previous 15.37%
Current 16.23%
Delta 0.86% R And D Intensity Decreased
Previous 1.58%
Current 1.47%
Delta -0.11% Sbc Intensity Increased
Previous 0.63%
Current 0.84%
Delta 0.21% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.